|
GAPVD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.058380E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.610700E-04 |
| Normal-vs-Stage2 |
4.757000E-01 |
| Normal-vs-Stage3 |
1.944030E-03 |
| Normal-vs-Stage4 |
2.152600E-01 |
| Stage1-vs-Stage2 |
2.322000E-01 |
| Stage1-vs-Stage3 |
5.833000E-01 |
| Stage1-vs-Stage4 |
9.803000E-01 |
| Stage2-vs-Stage3 |
9.966500E-02 |
| Stage2-vs-Stage4 |
4.222400E-01 |
| Stage3-vs-Stage4 |
7.402800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.798800E-04 |
| Normal-vs-AfricanAmerican |
6.179500E-02 |
| Normal-vs-Asian |
1.215410E-04 |
| Caucasian-vs-AfricanAmerican |
5.172000E-01 |
| Caucasian-vs-Asian |
1.493770E-01 |
| AfricanAmerican-vs-Asian |
9.279900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.010900E-04 |
| Normal-vs-Female |
2.458200E-01 |
| Male-vs-Female |
1.239990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.195550E-02 |
| Normal-vs-Extreme_Weight |
2.041700E-04 |
| Normal-vs-Obese |
1.112180E-01 |
| Normal-vs-Extreme_Obese |
1.559760E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.064200E-01 |
| Normal_Weight-vs-Obese |
3.604800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.214200E-01 |
| Extreme_Weight-vs-Obese |
1.531800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.898400E-01 |
| Obese-vs-Extreme_Obese |
6.562400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.992810E-01 |
| Normal-vs-Age(41-60Yrs) |
3.382200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.20030000003457E-06 |
| Normal-vs-Age(81-100Yrs) |
2.477400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.894400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.327600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.761000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.158500E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.250160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.888800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.522250E-02 |
| Normal-VS-Type2 PRCC |
4.185200E-04 |
| Normal-VS-KIRP CIMP |
6.677800E-01 |
| Normal-VS-Unclassified PRCC |
1.490580E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.182400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.968800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.772400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.723600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.949000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.155400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70311999999617E-05 |
| Normal-vs-N1 |
1.808170E-01 |
| Normal-vs-N2 |
6.420600E-01 |
| N0-vs-N1 |
2.114800E-01 |
| N0-vs-N2 |
4.806200E-01 |
| N1-vs-N2 |
9.747600E-01 |
|
|
